6/17/2019  7:19:00 PM Chg. +0.34 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
49.25USD +0.70% 7,362
Turnover: 361,115.01
-Bid Size: - -Ask Size: - 8.13 bill.USD 0.00% 52.56

Business description

DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease.
 

Management board & Supervisory board

CEO
Kent J. Thiry (bis 1.06.2019)
Management board
Joel Ackerman, Dr. Allen R. Nissenson, James K. Hilger, James O. Hearty, Javier J. Rodriguez (CEO ab 1.06.2019), Joseph C. Mello, Kathleen A. Waters, LeAnne Zumwalt, Michael D. Staffieri, Robert Lang
Supervisory board
Kent J. Thiry, Barbara J. Desoer, Charles G. Berg, Dr. William L. Roper, Javier J. Rodriguez (ab 1.06.2019), John M. Nehra, Pamela M. Arway, Pascal Desroches, Paul J. Diaz, Peter T. Grauer, Phyllis R. Yale
 

Company data

Name: DaVita Inc.
Address: 2000 16th Street,Denver, CO 80202, USA
Phone: +1-303-405-2100
Fax: -
E-mail: -
Internet: www.davita.com
Industry: Healthcare
Sector: Healthcare Providers
Sub sector: Healthcare Providers
End of financial year: 12/31
Free Float: 60.97%
IPO date: 3/8/2001

Investor relations

Name: Jim Gustafson
IR phone: +1-310-536-2585
IR-Fax: -
IR e-mail: ir@davita.com

Company calendar

CW 25 | 6/17/2019 General Shareholder Meeting
 

Main Shareholders

Freefloat
 
60.97%
Warren E. Buffett
 
23.18%
The Vanguard Group, Inc.
 
8.08%
BlackRock Inc.
 
7.77%